David Nguyen

David Nguyen

Auto-generated profile, based on publicly available information

David Nguyen

Scientific Center for Optical and Electron Microscopy (ScopeM), ETH Zürich

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2017 in Biomedical Optics Express
Verified
Journal Article
Closed access
PDF file
PMPaul J. Marchand
Paul J. Marchand
ABArno Bouwens
Arno Bouwens
DSDaniel Szlag
Daniel Szlag
DNDavid Nguyen
David Nguyen
ADAdrien Descloux
Adrien Descloux
TLTheo Lasser
Theo Lasser
We present a novel extended-focus optical coherence microscope (OCM) attaining 0.7 μm axial and 0.4 μm lateral resolution maintained over a depth of 40 μm, while preserving the advantages of Fourier domain OCM. Our system uses an ultra-broad spectrum from a supercontinuum laser source. As the spectrum spans from near-infrared to visible wavelengths (240 nm in bandwidth), we call the system visOCM. The combination of such a broad spectrum with a high-NA objective creates an almost isotropic 3D submicron resolution. We analyze the imaging performance of visOCM on microbead samples and demonstrate its image quality on cell cultures and ex-vivo brain tissue of both healthy and alzheimeric mice. In addition to neuronal cell bodies, fibers and plaques, visOCM imaging of brain tissue reveals fine vascular structures and sub-cellular features through its high spatial resolution. Sub-cellular structures were also observed in live cells and were further revealed through a protocol traditionally used for OCT angiography.

15 November 2017 in Biomedical Optics Express
Verified
Journal Article
Closed access
PDF file
DNDavid Nguyen
David Nguyen
PMPaul J. Marchand
Paul J. Marchand
APArielle L. Planchette
Arielle L. Planchette
JNJulia Nilsson
Julia Nilsson
MSMiguel Sison
Miguel Sison
TLTheo Lasser
Theo Lasser
In recent years, three-dimensional mesoscopic imaging has gained significant importance in life sciences for fundamental studies at the whole-organ level. In this manuscript, we present an optical projection tomography (OPT) method designed for imaging of the intact mouse brain. The system features an isotropic resolution of ~50 µm and an acquisition time of four to eight minutes, using a 3-day optimized clearing protocol. Imaging of the brain autofluorescence in 3D reveals details of the neuroanatomy, while the use of fluorescent labels displays the vascular network and amyloid deposition in 5xFAD mice, an important model of Alzheimer’s disease (AD). Finally, the OPT images are compared with histological slices.

17 October 2016 in Biomedical Optics Express
Verified
Journal Article
Open access
PDF file
CBCorinne Berclaz
Corinne Berclaz
DSDaniel Szlag
Daniel Szlag
DNDavid Nguyen
David Nguyen
JEJérôme Extermann
Jérôme Extermann
ABArno Bouwens
Arno Bouwens
TLTheo Lasser
Theo Lasser
In diabetes, pancreatic β-cells play a key role. These cells are clustered within structures called islets of Langerhans inside the pancreas and produce insulin, which is directly secreted into the blood stream. The dense vascularization of islets of Langerhans is critical for maintaining a proper regulation of blood glucose homeostasis and is known to be affected from the early stage of diabetes. The deep localization of these islets inside the pancreas in the abdominal cavity renders their in vivo visualization a challenging task. A fast label-free imaging method with high spatial resolution is required to study the vascular network of islets of Langerhans. Based on these requirements, we developed a label-free and three-dimensional imaging method for observing islets of Langerhans using extended-focus Fourier domain Optical Coherence Microscopy (xfOCM). In addition to structural imaging, this system provides three-dimensional vascular network imaging and dynamic blood flow information within islets of Langerhans. We propose our method to deepen the understanding of the interconnection between diabetes and the evolution of the islet vascular network.

10 April 2018 in Optics Letters
Verified
Journal Article
Closed access
PDF file
PMPaul J. Marchand
Paul J. Marchand
DSDaniel Szlag
Daniel Szlag
JEJérôme Extermann
Jérôme Extermann
ABArno Bouwens
Arno Bouwens
DNDavid Nguyen
David Nguyen
TLTheo Lasser
Theo Lasser
Extended-focus optical coherence tomography (xf-OCT) is a variant of optical coherence tomography (OCT) wherein the illumination and/or detection modes are engineered to provide a constant diffractionless lateral resolution over an extended depth of field (typically 3 to 10× the Rayleigh range). xf-OCT systems operating at 800 nm have been devised and used in the past to image brain structures at high-resolution in vivo, but are limited to ∼500  μm in penetration depth due to their short illumination wavelength. Here we present an xf-OCT system optimized to an image deeper within the cortex by using a longer illumination central wavelength of 1310 nm. The system offers a lateral resolution of 3 and 6.5 μm, over a depth of 900 μm and >1.5  mm using a 10× and 5× objective, respectively, in air. We characterize the system’s resolution using microbeads embedded in PDMS and demonstrate its capabilities by imaging the cortical structure and microvasculature in anesthetized mice to a depth of ∼0.8  mm. Finally, we illustrate the difference in penetration depths obtainable with the new system and an xf-OCT system operating at 800 nm.

28 May 2019 in Biomedical Optics Express
Verified
Journal Article
Closed access
PDF file
DNDavid Nguyen
David Nguyen
VUVirginie Uhlmann
Virginie Uhlmann
APArielle L. Planchette
Arielle L. Planchette
PMPaul J. Marchand
Paul J. Marchand
DVDimitri Van De Ville
Dimitri Van De Ville
ARAleksandra Radenovic
Aleksandra Radenovic
Alzheimer’s disease (AD) is characterized by amyloidosis of brain tissues. This phenomenon is studied with genetically-modified mouse models. We propose a method to quantify amyloidosis in whole 5xFAD mouse brains, a model of AD. We use optical projection tomography (OPT) and a random forest voxel classifier to segment and measure amyloid plaques. We validate our method in a preliminary cross-sectional study, where we measure 6136 ± 1637, 8477 ± 3438, and 17267 ± 4241 plaques (AVG ± SD) at 11, 17, and 31 weeks. Overall, this method can be used in the evaluation of new treatments against AD.

23 November 2018 in Motivation and Emotion
Verified
Journal Article
Closed access
PDF file
NSNicolas Sommet
Nicolas Sommet
DNDavid Nguyen
David Nguyen
KFKevin Fahrni
Kevin Fahrni
MJMartin Jobin
Martin Jobin
HNHa-Phong Nguyen
Ha-Phong Nguyen
FBFabrizio Butera
Fabrizio Butera